Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas. 1995

R W van der Maazen, and H O Thijssen, and J H Kaanders, and A de Koster, and A Keyser, and M J Prick, and J A Grotenhuis, and P Wesseling, and A J van der Kogel
Institute of Radiotherapy, University of Nijmegen, The Netherlands.

High grade malignant gliomas are among the most radioresistant human tumors and total doses up to 80 Gy are inadequate to achieve long-term local control in most of the patients. Hypoxia has been demonstrated in primary brain tumors and may be one of the reasons for their radioresistance. In experimental models carbogen breathing and nicotinamide have been shown to act against hypoxia by different mechanisms and both modalities were tested in 16 patients with supratentorial malignant gliomas in combination with a conventional radiotherapy scheme (50 Gy in 25 daily fractions). The present study was performed to determine the feasibility and toxicity of conventional radiotherapy combined with carbogen breathing and nicotinamide. The unexpectedly high incidence of acute liver toxicity, the possible increase of subacute and late CNS toxicity, and the absence of a higher effectivity led us to reconsider this new treatment modality for patients with malignant gliomas.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009536 Niacinamide An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. Nicotinamide,Vitamin B 3,Vitamin PP,3-Pyridinecarboxamide,Enduramide,Nicobion,Nicotinsäureamid Jenapharm,Papulex,Vitamin B3,3 Pyridinecarboxamide,B 3, Vitamin,B3, Vitamin,Jenapharm, Nicotinsäureamid
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D011832 Radiation Injuries Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in VERTEBRATES. Radiation Sickness,Radiation Syndrome,Injuries, Radiation,Injury, Radiation,Radiation Injury,Radiation Sicknesses,Radiation Syndromes,Sickness, Radiation,Sicknesses, Radiation,Syndrome, Radiation,Syndromes, Radiation
D011838 Radiation-Sensitizing Agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. Radiation Sensitizer,Radiosensitizing Agent,Radiosensitizing Agents,Agents, Radiation-Sensitizing,Radiation Sensitizers,Radiation Sensitizing Agents,Radiation-Sensitizing Drugs,Radiation-Sensitizing Effect,Radiation-Sensitizing Effects,Radiosensitizing Drugs,Radiosensitizing Effect,Radiosensitizing Effects,Agent, Radiosensitizing,Agents, Radiation Sensitizing,Agents, Radiosensitizing,Drugs, Radiation-Sensitizing,Drugs, Radiosensitizing,Effect, Radiation-Sensitizing,Effect, Radiosensitizing,Effects, Radiation-Sensitizing,Effects, Radiosensitizing,Radiation Sensitizing Drugs,Radiation Sensitizing Effect,Radiation Sensitizing Effects,Sensitizer, Radiation,Sensitizers, Radiation,Sensitizing Agents, Radiation
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002245 Carbon Dioxide A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals. Carbonic Anhydride,Anhydride, Carbonic,Dioxide, Carbon
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females

Related Publications

R W van der Maazen, and H O Thijssen, and J H Kaanders, and A de Koster, and A Keyser, and M J Prick, and J A Grotenhuis, and P Wesseling, and A J van der Kogel
June 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
R W van der Maazen, and H O Thijssen, and J H Kaanders, and A de Koster, and A Keyser, and M J Prick, and J A Grotenhuis, and P Wesseling, and A J van der Kogel
January 1994, Acta oncologica (Stockholm, Sweden),
R W van der Maazen, and H O Thijssen, and J H Kaanders, and A de Koster, and A Keyser, and M J Prick, and J A Grotenhuis, and P Wesseling, and A J van der Kogel
January 1992, BJR supplement,
R W van der Maazen, and H O Thijssen, and J H Kaanders, and A de Koster, and A Keyser, and M J Prick, and J A Grotenhuis, and P Wesseling, and A J van der Kogel
December 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
R W van der Maazen, and H O Thijssen, and J H Kaanders, and A de Koster, and A Keyser, and M J Prick, and J A Grotenhuis, and P Wesseling, and A J van der Kogel
August 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
R W van der Maazen, and H O Thijssen, and J H Kaanders, and A de Koster, and A Keyser, and M J Prick, and J A Grotenhuis, and P Wesseling, and A J van der Kogel
February 1997, International journal of radiation oncology, biology, physics,
R W van der Maazen, and H O Thijssen, and J H Kaanders, and A de Koster, and A Keyser, and M J Prick, and J A Grotenhuis, and P Wesseling, and A J van der Kogel
November 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
R W van der Maazen, and H O Thijssen, and J H Kaanders, and A de Koster, and A Keyser, and M J Prick, and J A Grotenhuis, and P Wesseling, and A J van der Kogel
May 1990, Nihon Gan Chiryo Gakkai shi,
R W van der Maazen, and H O Thijssen, and J H Kaanders, and A de Koster, and A Keyser, and M J Prick, and J A Grotenhuis, and P Wesseling, and A J van der Kogel
January 2001, Radiation research,
R W van der Maazen, and H O Thijssen, and J H Kaanders, and A de Koster, and A Keyser, and M J Prick, and J A Grotenhuis, and P Wesseling, and A J van der Kogel
September 1989, Gan no rinsho. Japan journal of cancer clinics,
Copied contents to your clipboard!